Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Zeitz

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Praxis|September 19, 2019
[From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases]Solvey Schüle, Diana Frey, Luc Biedermann, et al.
Plos One|May 7, 2016
Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative ColitisSofia Roth, Marianne R Spalinger, Claudia Gottier, et al.
The American Journal of Gastroenterology|September 3, 2010
Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohortStephan R Vavricka, Lionel Brun, Pierluigi Ballabeni, et al.
Inflammatory Bowel Diseases|April 19, 2018
The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD CohortMatiar Madanchi, Stefania Fagagnini, Nicolas Fournier, et al.
Therapeutic Advances in Gastroenterology|February 13, 2020
Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort studyLorenz Grob, Sena Bluemel, Luc Biedermann, et al.
Inflammatory Bowel Diseases|July 30, 2014
Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISHLuc Biedermann, Karin Brülisauer, Jonas Zeitz, et al.
Plos One|May 24, 2016
The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel DiseaseMarius Vögelin, Luc Biedermann, Pascal Frei, et al.
European Journal of Gastroenterology & Hepatology|August 3, 2016
Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experienceJonas Bontà, Jonas Zeitz, Pascal Frei, et al.
Inflammatory Bowel Diseases|October 12, 2011
Systematic assessment of factors influencing preferences of Crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL)Stephan R Vavricka, Nicoletta Bentele, Michael Scharl, et al.
European Journal of Gastroenterology & Hepatology|November 24, 2016
Patients' views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?Jonas Zeitz, Marina Bissig, Christiane Barthel, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Praxis|September 19, 2019
[From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases]Solvey Schüle, Diana Frey, Luc Biedermann, et al.
Plos One|May 7, 2016
Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative ColitisSofia Roth, Marianne R Spalinger, Claudia Gottier, et al.
The American Journal of Gastroenterology|September 3, 2010
Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohortStephan R Vavricka, Lionel Brun, Pierluigi Ballabeni, et al.
Inflammatory Bowel Diseases|April 19, 2018
The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD CohortMatiar Madanchi, Stefania Fagagnini, Nicolas Fournier, et al.
Therapeutic Advances in Gastroenterology|February 13, 2020
Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort studyLorenz Grob, Sena Bluemel, Luc Biedermann, et al.
Inflammatory Bowel Diseases|July 30, 2014
Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISHLuc Biedermann, Karin Brülisauer, Jonas Zeitz, et al.
Plos One|May 24, 2016
The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel DiseaseMarius Vögelin, Luc Biedermann, Pascal Frei, et al.
European Journal of Gastroenterology & Hepatology|August 3, 2016
Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experienceJonas Bontà, Jonas Zeitz, Pascal Frei, et al.
Inflammatory Bowel Diseases|October 12, 2011
Systematic assessment of factors influencing preferences of Crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL)Stephan R Vavricka, Nicoletta Bentele, Michael Scharl, et al.
European Journal of Gastroenterology & Hepatology|November 24, 2016
Patients' views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?Jonas Zeitz, Marina Bissig, Christiane Barthel, et al.
Pageof 6